![Incidence, associated factors, and effect on renal function of amoxicillin crystalluria in patients receiving high doses of intravenous amoxicillin (The CRISTAMOX Study): A cohort study - eClinicalMedicine Incidence, associated factors, and effect on renal function of amoxicillin crystalluria in patients receiving high doses of intravenous amoxicillin (The CRISTAMOX Study): A cohort study - eClinicalMedicine](https://www.thelancet.com/cms/asset/995b0ec5-56c4-41ca-a10d-a9ecfa478be7/gr1.jpg)
Incidence, associated factors, and effect on renal function of amoxicillin crystalluria in patients receiving high doses of intravenous amoxicillin (The CRISTAMOX Study): A cohort study - eClinicalMedicine
![Pharmaceutics | Free Full-Text | Pharmacokinetic/Pharmacodynamic Evaluation of Aztreonam/Amoxicillin/Clavulanate Combination against New Delhi Metallo-β-Lactamase and Serine-β-Lactamase Co-Producing Escherichia coli and Klebsiella pneumoniae Pharmaceutics | Free Full-Text | Pharmacokinetic/Pharmacodynamic Evaluation of Aztreonam/Amoxicillin/Clavulanate Combination against New Delhi Metallo-β-Lactamase and Serine-β-Lactamase Co-Producing Escherichia coli and Klebsiella pneumoniae](https://www.mdpi.com/pharmaceutics/pharmaceutics-15-00251/article_deploy/html/images/pharmaceutics-15-00251-g003.png)
Pharmaceutics | Free Full-Text | Pharmacokinetic/Pharmacodynamic Evaluation of Aztreonam/Amoxicillin/Clavulanate Combination against New Delhi Metallo-β-Lactamase and Serine-β-Lactamase Co-Producing Escherichia coli and Klebsiella pneumoniae
![Is the standard dose of amoxicillin-clavulanic acid sufficient? | BMC Pharmacology and Toxicology | Full Text Is the standard dose of amoxicillin-clavulanic acid sufficient? | BMC Pharmacology and Toxicology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F2050-6511-15-38/MediaObjects/40360_2014_Article_329_Fig4_HTML.jpg)
Is the standard dose of amoxicillin-clavulanic acid sufficient? | BMC Pharmacology and Toxicology | Full Text
![These highlights do not include all the information needed to use AMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION USP, 600 mg/42.9 mg per 5 mL safely and effectively. See full prescribing information These highlights do not include all the information needed to use AMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION USP, 600 mg/42.9 mg per 5 mL safely and effectively. See full prescribing information](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=amoxicillin-and-clavulanate-potassium-for-oral-sus-5.jpg&id=702187)